CS/SB 612 — Blood Clot and Pulmonary Embolism Policy Workgroup
by Health Policy Committee and Senators Yarborough, Gruters, Davis, Book, Osgood, Harrell, Martin, Avila, Collins, Burton, Pizzo, DiCeglie, Berman, Burgess, Calatayud, Wright, Jones, Powell, Hutson, Garcia, Polsky, Torres, Stewart, Passidomo, Albritton, Baxley, Boyd, Bradley, Brodeur, Broxson, Grall, Hooper, Ingoglia, Mayfield, Perry, Rodriguez, Rouson, Simon, Thompson, and Trumbull
This summary is provided for information only and does not represent the opinion of any Senator, Senate Officer, or Senate Office.
Prepared by: Health Policy Committee (HP)
The bill creates the “Emily Adkins Prevention Act” and establishes a blood clot and pulmonary embolism policy workgroup composed of health care providers, patients who have experienced blood clots, family members of patients who have died from blood clots, advocates, and other interested parties and associations. The Secretary of Health Care Administration and the State Surgeon General share responsibility for the workgroup.
The purpose of the workgroup is to identify the prevalence, impacts, and health outcomes of persons experiencing blood clots and pulmonary embolisms; the standards of care for surveillance, detection, and treatment; and emerging treatments and research. The workgroup is charged with developing a risk surveillance system and policy recommendations for improved standards of care, surveillance, detection, and patient and family education relating to blood clots and pulmonary embolisms.
The Secretary of Health Care Administration is charged with reporting the workgroup’s findings and recommendations to the Governor and Legislature, with a final report to be submitted by January 4, 2025.
If approved by the Governor, or allowed to become law without the Governor’s signature, these provisions take effect July 1, 2023.
Vote: Senate 39-0; House 114-0